Corcept Therapeutics News, Corcept Therapeutics Quote, CORT Quote

Corcept Therapeutics (NQ:CORT) Delayed: 87.13 --0 (-0%)

Prev. Close

$87.13

Today 6M 1Y 5Y

Open

$87.13

52 Wk High

$10.00

52 Wk Low

$3.22

Day High

$87.13

Day Low

$87.13

P/E

N/A

EPS

$-0.46

Volume

372

Friends, Peers and Foes (?): KD, PYPL, SMR, TEVA, ITGR (more...)

ALERTS | RSS

Oct 26, 2026 08:00 AM Corcept's Lifyorli combo shows PFS gains in ovarian cancer trial
Oct 26, 2026 08:00 AM Corcept Reports Positive Results from Phase 2 BELLA Trial of Lifyorli® Combined with Nab-Paclitaxel and Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer
Oct 23, 2026 12:20 PM Genmab stock surges 9% following positive phase 3 ovarian cancer trial results
Oct 20, 2026 04:00 PM 2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
Oct 20, 2026 02:32 PM Corcept Therapeutics (CORT) spreader of 2500 contracts of January 120 and 160 calls
Oct 16, 2026 06:25 PM Form 4 CORCEPT THERAPEUTICS For: Oct 15 Filed by: WILSON JAMES N
Oct 5, 2026 07:59 PM Form 4 CORCEPT THERAPEUTICS For: Oct 02 Filed by: Vieira Roberto Wandenkolk
Oct 5, 2026 07:54 PM Form 4 CORCEPT THERAPEUTICS For: Oct 01 Filed by: Lyon Joseph Douglas
Oct 5, 2026 07:49 PM Form 4 CORCEPT THERAPEUTICS For: Oct 01 Filed by: Maduck Sean
Oct 5, 2026 07:45 PM Form 4 CORCEPT THERAPEUTICS For: Oct 01 Filed by: Gunn Justin Frederick

Entities mentioned with CORT

View All Entities